{"transactions":[{"id":3998910,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-10","kind":"exercise","acquired":false,"shares":20434,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":40866,"derivative":{"underlying":"Common Stock","underlying_shares":20434},"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":3998909,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":3998908,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-10","kind":"tax_withholding","acquired":false,"shares":5653,"price":4.51,"value":25495.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":123486,"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":3998907,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-10","kind":"exercise","acquired":true,"shares":20434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":129139,"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":3998906,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":6896,"price":4.51,"value":31100.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":108705,"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":3998905,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:36:31.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":115601,"source":{"system":"sec-edgar","filing":"0001055726-18-000009","document":"wf-form4_152098057831916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000009/wf-form4_152098057831916.xml","form_type":"4"}},{"id":4008716,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-08T00:42:15.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":82700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares will vest on March 5, 2019; 27,567 shares will vest on March 5, 2020; 27,566 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares will vest on March 5, 2019; 27,567 shares will vest on March 5, 2020; 27,566 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares will vest on March 5, 2019; 27,567 shares will vest on March 5, 2020; 27,566 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":82700,"derivative":{"underlying":"Common Stock","underlying_shares":82700},"source":{"system":"sec-edgar","filing":"0001055726-18-000003","document":"wf-form4_152046971988104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000003/wf-form4_152046971988104.xml","form_type":"4"}},{"id":4008715,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2018-03-08T00:42:15.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":126500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 126,500 options is as follows: 31,625 shares vested on March 5, 2018; 31,625 shares will vest on March 5, 2019; 31,625 shares will vest on March 5, 2020; 31,625 shares will vest on March 5, 2021."}],"balance_after":126500,"derivative":{"exercise_price":4.29,"exercise_date":"2018-03-05","expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":126500},"source":{"system":"sec-edgar","filing":"0001055726-18-000003","document":"wf-form4_152046971988104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000003/wf-form4_152046971988104.xml","form_type":"4"}},{"id":4008714,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-08T00:42:15.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001055726-18-000003","document":"wf-form4_152046971988104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000003/wf-form4_152046971988104.xml","form_type":"4"}},{"id":4008713,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-08T00:42:15.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":2815,"price":4.29,"value":12076.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":90601,"source":{"system":"sec-edgar","filing":"0001055726-18-000003","document":"wf-form4_152046971988104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000003/wf-form4_152046971988104.xml","form_type":"4"}},{"id":4008712,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-08T00:42:15.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":93416,"source":{"system":"sec-edgar","filing":"0001055726-18-000003","document":"wf-form4_152046971988104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000003/wf-form4_152046971988104.xml","form_type":"4"}},{"id":4389246,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":61300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":61300,"derivative":{"underlying":"Common Stock","underlying_shares":61300},"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389245,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":100000,"price":6.68,"value":668000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 100,000 options is as follows: 25,000 shares vested on March 10, 2017; 25,000 shares will vest on March 10, 2018; 25,000 shares will vest on March 10, 2019; 25,000 shares will vest on March 10, 2020"}],"balance_after":100000,"derivative":{"exercise_price":6.68,"exercise_date":"2017-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389244,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389243,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":1859,"price":6.68,"value":12418.12,"ownership":{"direct":true},"balance_after":85083,"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389242,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":6077,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These restricted stock units vested 100% on the March 10, 2017 grant date."}],"balance_after":86942,"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389241,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":7648,"price":6.61,"value":50553.28,"ownership":{"direct":true},"balance_after":80865,"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4389240,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:43:44.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":88513,"source":{"system":"sec-edgar","filing":"0001055726-17-000010","document":"wf-form4_148944140934031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000010/wf-form4_148944140934031.xml","form_type":"4"}},{"id":4398316,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-07T21:46:14.000Z","date":"2017-03-05","kind":"exercise","acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":8333,"derivative":{"underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001055726-17-000005","document":"wf-form4_148892316074261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000005/wf-form4_148892316074261.xml","form_type":"4"}},{"id":4398315,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-07T21:46:14.000Z","date":"2017-03-06","kind":"tax_withholding","acquired":false,"shares":3067,"price":6.95,"value":21315.65,"ownership":{"direct":true},"balance_after":63513,"source":{"system":"sec-edgar","filing":"0001055726-17-000005","document":"wf-form4_148892316074261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000005/wf-form4_148892316074261.xml","form_type":"4"}},{"id":4398314,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-07T21:46:14.000Z","date":"2017-03-05","kind":"exercise","acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":66580,"source":{"system":"sec-edgar","filing":"0001055726-17-000005","document":"wf-form4_148892316074261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000005/wf-form4_148892316074261.xml","form_type":"4"}},{"id":4503759,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2017-01-04T20:52:45.000Z","date":"2017-01-04","kind":"exercise","acquired":false,"shares":3680,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.12,"exercise_date":"2010-01-18","expiration_date":"2017-01-18","underlying":"Common Stock","underlying_shares":3680},"source":{"system":"sec-edgar","filing":"0001055726-17-000001","document":"wf-form4_148356315199822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000001/wf-form4_148356315199822.xml","form_type":"4"}},{"id":4503758,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2017-01-04T20:52:45.000Z","date":"2017-01-04","kind":"exercise","acquired":false,"shares":6133,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.12,"exercise_date":"2010-01-05","expiration_date":"2017-01-05","underlying":"Common Stock","underlying_shares":6133},"source":{"system":"sec-edgar","filing":"0001055726-17-000001","document":"wf-form4_148356315199822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000001/wf-form4_148356315199822.xml","form_type":"4"}},{"id":4503757,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-01-04T20:52:45.000Z","date":"2017-01-04","kind":"exercise","acquired":true,"shares":3680,"price":6.12,"value":22521.6,"ownership":{"direct":true},"balance_after":58247,"source":{"system":"sec-edgar","filing":"0001055726-17-000001","document":"wf-form4_148356315199822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000001/wf-form4_148356315199822.xml","form_type":"4"}},{"id":4503756,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":168359,"kind":"person","name":"Sardesai Niranjan","position":1,"cik":"0001464547","reported_name":"Sardesai Niranjan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-01-04T20:52:45.000Z","date":"2017-01-04","kind":"exercise","acquired":true,"shares":6133,"price":6.12,"value":37533.96,"ownership":{"direct":true},"balance_after":54567,"source":{"system":"sec-edgar","filing":"0001055726-17-000001","document":"wf-form4_148356315199822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000001/wf-form4_148356315199822.xml","form_type":"4"}}]}